LtoR-Chief Technical Officer & Co-founder, Rafael Fietzek and Chief Executive Officer & co-founder Stéphane Foulard.

COMPREDICT Secures $15M Series B Funding to Propel Automotive Innovation

In a strategic move poised to revolutionize the automotive industry, COMPREDICT, a leader in AI-powered solutions for software-defined vehicles, has announced a significant milestone with a $15 million Series B funding round. This round was led by Woven Capital, Toyota’s growth fund, marking a pivotal moment in COMPREDICT’s journey to redefine vehicle functionality through advanced…

Read More

Faye Secures $31 Million in Series B Funding to Revolutionize Travel Protection

Faye, the acclaimed travel platform known for integrating insurance, assistance, and financial solutions, has successfully raised $31 million in Series B funding. This latest round elevates Faye’s total funding to $49 million. The investment was spearheaded by Portage, with notable contributions from Lumir Ventures and continued support from existing backers F2 Venture Capital, Viola Ventures,…

Read More

ProofPilot Revolutionizes Clinical Trials with Series C Funding Boost

New York-based ProofPilot, a frontrunner in the Clinical Experience Platform (CXP) space, has announced the successful closing of its Series C funding round. Sopris Capital led the investment, with participation from Mitsui & Co. (U.S.A.), Inc. This significant investment underscores the growing recognition of ProofPilot’s innovative approach to clinical trials. While advancements in data capture…

Read More
CEO Bert Baeck timeseer.AI

OTB Ventures Invests in Timeseer.AI, Paving the Way for Next-Gen Data Operations Innovation

In a significant move underscoring the growing importance of data quality in AI-driven industries, Amsterdam-based OTB Ventures has announced a strategic investment in Timeseer.AI, an innovative data operations (DataOps) firm headquartered in Antwerp. This infusion of capital, the exact amount of which remains undisclosed, marks a pivotal step for both companies as they aim to…

Read More

Biophyle Unveils Groundbreaking Accelerator Program for Clinical-Stage Biotech Innovations and Local Research Training

In a major boost to healthcare innovation, SymBiosis and HealthTech Arkansas have announced the launch of the biophyle Trial Accelerator, a pioneering initiative aimed at bridging the gap between cutting-edge clinical-stage biotherapeutics and Arkansas’ healthcare ecosystem. This strategic program is designed to catalyze the commercialization of novel treatments by connecting biotherapeutic innovations with clinical trial…

Read More

Gigpro Secures $16M Series A Financing to Revolutionize Hospitality Labor Market

Gigpro, a trailblazer in on-demand labor solutions for the hospitality sector, has successfully closed a $16 million Series A funding round. This substantial investment was spearheaded by Foundry, with notable participation from Stage 1 Ventures, Stage 2 Capital, and Detroit Venture Partners. The new capital will catalyze Gigpro’s mission to reshape the gig economy and…

Read More

Antiverse Secures £3.5M to Revolutionize Antibody Design and Address Complex Therapeutic Targets

Antiverse, a forward-thinking techbio company focused on antibody design for challenging therapeutic targets, has successfully raised an additional £3.5M ($4.6M) in its latest funding round. This investment elevates the total funding to £7.2M ($10.1M) and will significantly bolster Antiverse’s growth initiatives, including the expansion of its research facilities in Boston and Prague. The funding was…

Read More

node.vc Secures €71M Fund to Propel Nordic Entrepreneurship

In a significant boost for the Nordic startup ecosystem, venture capital firm node.vc has successfully closed a €71 million fund aimed at fostering early-stage entrepreneurial ventures across the region. The firm, composed of seasoned professionals from leading startups and scaleups—including eye-tracking innovator Tobii and video game powerhouse Paradox Interactive—is committed to creating a robust support…

Read More